Gonorrhoea Resistance Assessment by Nucleic Acid Detection (GRANDII)

NAUnknownINTERVENTIONAL
Enrollment

1,626

Participants

Timeline

Start Date

April 26, 2022

Primary Completion Date

July 30, 2023

Study Completion Date

July 30, 2024

Conditions
Drug Resistance, MicrobialAntimicrobial StewardshipGonorrhea
Interventions
OTHER

Resistance guided treatment for gonorrhoea infection

For cases of gonorrhoea infection treated at the return visit, a nucleic acid assay will be used to determine individual eligibility for ciprofloxacin treatment

Trial Locations (1)

0733651111

University of Queensland, Brisbane

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Kirby Institute

OTHER_GOV

collaborator

Monash University

OTHER

collaborator

South Australian Health and Medical Research Institute

OTHER

collaborator

University of Melbourne

OTHER

collaborator

University of California, Los Angeles

OTHER

collaborator

Griffith University

OTHER

collaborator

Queensland Health

OTHER_GOV

collaborator

St Vincent's Hospital, Sydney

OTHER

collaborator

SpeeDx Pty Ltd

INDUSTRY

collaborator

NSW Health Pathology

UNKNOWN

collaborator

University of Sydney

OTHER

lead

The University of Queensland

OTHER